Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1984;62(3):433–437.

Plasmodium falciparum: mefloquine resistance produced in vitro*

C Lambros, J D Notsch
PMCID: PMC2536315  PMID: 6380785

Abstract

Camp and Smith strains of the human malaria parasite Plasmodium falciparum became resistant to mefloquine after continuous cultivation in the presence of the drug. The 50% inhibitory dose (ID50) values for mefloquine, as assessed by [3H]hypoxanthine incorporation, were found to have increased 4-fold, from 3 μg/l to 12 μg/l. The ID50 values obtained by morphological examination of the cultures increased 10-fold. Resistance was stable in both strains either when grown in a drug-free medium or when kept frozen in liquid nitrogen. The mefloquine-resistant Camp strain remained sensitive to chloroquine and amodiaquine, and became slightly more resistant to quinine; there was increased sensitivity to pyrimethamine. The mefloquine-resistant Smith strain remained sensitive to amodiaquine and resistant to pyrimethamine; there was increased resistance to quinine, and an increase in sensitivity to chloroquine.

Full text

PDF
433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacchi C. J., Lambros C., Ellenbogen B. B., Penkovsky L. N., Sullivan W., Eyinna E. E., Hutner S. H. Drug-resistant Leptomonas: cross-resistance in trypanocide-resistant clones. Antimicrob Agents Chemother. 1975 Dec;8(6):688–692. doi: 10.1128/aac.8.6.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boudreau E. F., Webster H. K., Pavanand K., Thosingha L. Type II mefloquine resistance in Thailand. Lancet. 1982 Dec 11;2(8311):1335–1335. doi: 10.1016/s0140-6736(82)91532-x. [DOI] [PubMed] [Google Scholar]
  3. Brockelman C. R., Monkolkeha S., Tanariya P. Decrease in susceptibility of Plasmodium falciparum to mefloquine in continuous culture. Bull World Health Organ. 1981;59(2):249–252. [PMC free article] [PubMed] [Google Scholar]
  4. Brockelman C. R., Tan-Ariya P. Efficacy of Fansidar against Plasmodium falciparum in continuous culture. Am J Trop Med Hyg. 1982 Sep;31(5):913–918. doi: 10.4269/ajtmh.1982.31.913. [DOI] [PubMed] [Google Scholar]
  5. Bruce-Chwatt L. J. The Manson Oration, May 1979. Man against malaria: conquest or defeat. Trans R Soc Trop Med Hyg. 1979;73(6):605–617. doi: 10.1016/0035-9203(79)90002-6. [DOI] [PubMed] [Google Scholar]
  6. Desjardins R. E., Canfield C. J., Haynes J. D., Chulay J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979 Dec;16(6):710–718. doi: 10.1128/aac.16.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kazim M., Puri S. K., Dutta G. P. Chemotherapeutic studies with mefloquine and selection of a mefloquine resistant strain of Plasmodium berghei. Indian J Med Res. 1979 Dec;70 (Suppl):95–102. [PubMed] [Google Scholar]
  8. Lambros C., Childs G. E., Notsch J. D., Scovill J. P., Klayman D. L., Davidson D. E., Jr In vitro assessment of 2-acetylpyridine thiosemicarbazones against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother. 1982 Dec;22(6):981–984. doi: 10.1128/aac.22.6.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nguyen-Dinh P., Trager W. Chloroquine resistance produced in vitro in an African strain of human malaria. Science. 1978 Jun 23;200(4348):1397–1398. doi: 10.1126/science.351801. [DOI] [PubMed] [Google Scholar]
  10. Rieckmann K. H., López Antuñano F. J. Chloroquine resistance of Plasmodium falciparum in Brazil detected by a simple in vitro method. Bull World Health Organ. 1971;45(2):157–167. [PMC free article] [PubMed] [Google Scholar]
  11. Young M. D., Johnson C. M. Plasmodium falciparum malaria in Panama resistant to 4-aminoquinoline drugs. Am J Trop Med Hyg. 1972 Jan;21(2):13–17. doi: 10.4269/ajtmh.1972.21.13. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES